Date published: 2025-11-29

1-800-457-3801

SCBT Portrait Logo
Seach Input

VU 0360172 (CAS 1309976-62-2)

0.0(0)
Write a reviewAsk a question

See product citations (1)

Alternate Names:
N-Cyclobutyl-6-[2-(3-fluorophenyl)ethynyl]-3-pyridinecarboxamide Hydrochloride
Application:
VU 0360172 is Positive allosteric modulator of mGluR-5 receptors
CAS Number:
1309976-62-2
Molecular Weight:
330.78
Molecular Formula:
C18H15FN2O•HCl
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

VU 0360172 is selective for mGlu5 (EC50 = 16 nM Ki = 195 nM). It displays efficacy in regulating CNS function in human embryonic kidney cell and rat cortical astrocyte. VU 0360172 displays no significant activity at mGlu1, mGlu2 or mGlu4 receptors.


VU 0360172 (CAS 1309976-62-2) References

  1. Metabotropic glutamate receptors: physiology, pharmacology, and disease.  |  Niswender, CM. and Conn, PJ. 2010. Annu Rev Pharmacol Toxicol. 50: 295-322. PMID: 20055706
  2. Discovery of novel allosteric modulators of metabotropic glutamate receptor subtype 5 reveals chemical and functional diversity and in vivo activity in rat behavioral models of anxiolytic and antipsychotic activity.  |  Rodriguez, AL., et al. 2010. Mol Pharmacol. 78: 1105-23. PMID: 20923853
  3. Functional impact of allosteric agonist activity of selective positive allosteric modulators of metabotropic glutamate receptor subtype 5 in regulating central nervous system function.  |  Noetzel, MJ., et al. 2012. Mol Pharmacol. 81: 120-33. PMID: 22021324
  4. Modulation of pyramidal cell output in the medial prefrontal cortex by mGluR5 interacting with CB1.  |  Kiritoshi, T., et al. 2013. Neuropharmacology. 66: 170-8. PMID: 22521499
  5. Potentiation of mGlu5 receptors with the novel enhancer, VU0360172, reduces spontaneous absence seizures in WAG/Rij rats.  |  D'Amore, V., et al. 2013. Neuropharmacology. 66: 330-8. PMID: 22705340
  6. CB1 augments mGluR5 function in medial prefrontal cortical neurons to inhibit amygdala hyperactivity in an arthritis pain model.  |  Ji, G. and Neugebauer, V. 2014. Eur J Neurosci. 39: 455-66. PMID: 24494685
  7. Cognitive enhancers (Nootropics). Part 1: drugs interacting with receptors. Update 2014.  |  Froestl, W., et al. 2014. J Alzheimers Dis. 41: 961-1019. PMID: 24898652
  8. Mechanics and biology in intervertebral disc degeneration: a vicious circle.  |  Vergroesen, PP., et al. 2015. Osteoarthritis Cartilage. 23: 1057-70. PMID: 25827971
  9. Increased Metabotropic Glutamate Receptor 5 Signaling Underlies Obsessive-Compulsive Disorder-like Behavioral and Striatal Circuit Abnormalities in Mice.  |  Ade, KK., et al. 2016. Biol Psychiatry. 80: 522-33. PMID: 27436084
  10. Aß Facilitates LTD at Schaffer Collateral Synapses Preferentially in the Left Hippocampus.  |  O'Riordan, KJ., et al. 2018. Cell Rep. 22: 2053-2065. PMID: 29466733
  11. Branched Photoswitchable Tethered Ligands Enable Ultra-efficient Optical Control and Detection of G Protein-Coupled Receptors In Vivo.  |  Acosta-Ruiz, A., et al. 2020. Neuron. 105: 446-463.e13. PMID: 31784287
  12. The tripartite glutamatergic synapse.  |  Lalo, U., et al. 2021. Neuropharmacology. 199: 108758. PMID: 34433089

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

VU 0360172, 10 mg

sc-475934
10 mg
$158.00

VU 0360172, 50 mg

sc-475934A
50 mg
$668.00